Role of Acute Graft-Versus-Host Disease in the Risk of Bacteremia and Invasive Fungal Disease after Allogeneic Hemopoietic Stem Cell Transplantation in Children. Results from a Single-Center Observational Study

被引:21
|
作者
Castagnola, Elio [1 ]
Bagnasco, Francesca [2 ]
Bandettini, Roberto [3 ]
Caviglia, Ilaria [1 ]
Morreale, Giuseppe [4 ]
Lanino, Edoardo [4 ]
Giardino, Stefano [4 ]
Moroni, Cristina [1 ]
Haupt, Riccardo [2 ]
Faraci, Maura [4 ]
机构
[1] Ist Giannina Gaslini, Infect Dis Unit, I-16147 Genoa, Italy
[2] Ist Giannina Gaslini, Epidemiol Biostat & Comm Unit, I-16147 Genoa, Italy
[3] Ist Giannina Gaslini, Lab Anal, I-16147 Genoa, Italy
[4] Ist Giannina Gaslini, Dept Haematol Oncol, HSCT Unit, I-16147 Genoa, Italy
关键词
Acute graft-versus-host disease; Bacteremia; Invasive fungal disease; Allogeneic hemopoietic stem; cell transplantation; Children; INFECTIOUS COMPLICATIONS; EPIDEMIOLOGY; BLOOD; NEUTROPENIA; RECIPIENTS; MYCOSES; 1ST;
D O I
10.1016/j.bbmt.2014.03.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data on epidemiology of severe infectious complications, ie, bacteremia or invasive fungal disease (IFD), in children with acute graft-versus-host disease (aGVHD) after allogeneic hemopoietic stem cell transplantation (HSCT) are scarce. In a retrospective, single-center study, we analyzed the risk (hazard ratio [HR]) and the rate (episodes/1000 patients days at risk) of bacteremias and IFD in children receiving allogeneic HSCT, according to the type of donor (matched related [MRD] or alternative [AD]) and presence and grade of aGVHD. From 2000 to 2009, 198 children receiving 217 allogeneic HSCT developed 134 severe infectious episodes (103 bacteremias and 31 IFD). The type of donor (AD versus MRD) was the most important risk factor for the severe infections (P =.0052). In separate multivariable analysis for bacteremia and IFD, children receiving an AD HSCT had increased HR and rate of bacteremia compared with those receiving a MRD transplantation (P =.0171 and P =.0001, respectively), whereas the HR and the rate of IFD were significantly influenced by the grade of aGVHD (P =.0002 and P <.0001, respectively). Finally, infectious episodes occurred late after HSCT, especially in presence of severe aGVHD, and bacteremias were 3 to 6 times more frequent than IFD. These data may be important to design management strategies of infections in pediatric allogeneic HSCT. (C) 2014 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1068 / 1073
页数:6
相关论文
共 50 条
  • [1] Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study
    Grube, Matthias
    Holler, Ernst
    Weber, Daniela
    Holler, Barbara
    Herr, Wolfgang
    Wolff, Daniel
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1781 - 1791
  • [2] Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Center Experience
    Wang, Feiyan
    Cai, Bo
    Wang, Li
    Gu, Zhenyang
    Luo, Lan
    Wei, Huaping
    Zhao, Shasha
    Guan, Lixun
    Wang, Xiaoyu
    Wang, Lili
    Liu, Daihong
    Gao, Chunji
    [J]. ANNALS OF TRANSPLANTATION, 2017, 22 : 58 - 65
  • [3] Lung Transplantation for Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-center Experience
    Shitenberg, Dorit
    Pertzov, Barak
    Heching, Moshe
    Shostak, Yael
    Shtraichman, Osnat
    Rosengarten, Dror
    Yeshurun, Moshe
    Peysakhovich, Yury
    Barac, Yaron
    Kramer, Mordechai R.
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2023, 25 (03): : 227 - 232
  • [4] Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study
    Hua Jin
    Zhiping Fan
    Fen Huang
    Yanyan Chai
    Li Xuan
    Ren Lin
    Na Xu
    Jieyu Ye
    Jing Sun
    Qifa Liu
    [J]. Infection, 2019, 47 : 275 - 284
  • [5] Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study
    Jin, Hua
    Fan, Zhiping
    Huang, Fen
    Chai, Yanyan
    Xuan, Li
    Lin, Ren
    Xu, Na
    Ye, Jieyu
    Sun, Jing
    Liu, Qifa
    [J]. INFECTION, 2019, 47 (02) : 275 - 284
  • [6] Efficacy of Infliximab for the Treatment of Acute Gastrointestinal Graft-versus-Host Disease in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
    Suh, J. K.
    Lee, S. W.
    Koh, K-N.
    Choi, E. S.
    Im, H. J.
    Seo, J. J.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S181 - S181
  • [7] Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Smith, TL
    Folloder, J
    Khouri, I
    Ueno, NT
    Mehra, R
    Körbling, M
    Huh, YO
    Giralt, S
    Gajewski, J
    Donato, M
    Cleary, K
    Claxton, D
    Braunschweig, I
    van Besien, K
    Andersson, BS
    Anderlini, P
    Champlin, R
    [J]. BLOOD, 1999, 94 (04) : 1465 - 1470
  • [8] Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children
    Kondo, M
    Kojima, S
    Horibe, K
    Kato, K
    Matsuyama, T
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 (07) : 727 - 730
  • [9] Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children
    M Kondo
    S Kojima
    K Horibe
    K Kato
    T Matsuyama
    [J]. Bone Marrow Transplantation, 2001, 27 : 727 - 730
  • [10] Vedolizumab in highly resistant acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation: A single-center pediatric series
    Rosa, Monika
    Jarmolinski, Tomasz
    Miskiewicz-Migon, Izabella
    Liszka, Karolina
    Miskiewicz-Bujna, Justyna
    Panasiuk, Anna
    Fraczkiewicz, Jowita
    Ussowicz, Marek
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (03): : 345 - 350